Most Recent
Gilbert + Tobin launches tax controversy practice with EY partner
Gilbert + Tobin has hired a senior tax lawyer from EY to build a tax controversy practice at the firm.
Tesla may face ‘seriously bad time’ in self-driving cars class action, judge warns
A judge has expressed shock that only 2,000 documents have been produced in a class action against Tesla over self-driving cars and threatened the Elon Musk-run car maker with a "a seriously bad time" if he finds the discovery is lacking.
Construction PRO
Lendlease says KPMG partner shared confidential info with Westpac tender team
The CEO of Lendlease has confirmed a whistleblower's claim that a KPMG audit partner accessed confidential Lendlease board papers which were then shared with a team pursuing an audit tender with Westpac.
Coles misled customers with ‘Down Down’ discounts, judge finds
A judge has found Coles engaged in misleading and deceptive conduct when advertising products with a 'Down Down' discount, in a win for the consumer regulator and a class action.
Trial pushed back in AstraZeneca IP case against Pharmacor
Trial in AstraZeneca's patent infringement case over Pharmacor's plans to launch a cheaper version of diabetes drug Forxiga has been delayed to October, after the generic drug maker got the all-clear to revise its cross-claim.
Ex-Mastercard sales manager says he lied to finance team on 7-Eleven deal
A former Mastercard business development director has admitted at trial to lying to the payments giant's finance department about the risk of 7-Eleven routing transactions to EFTPOS to seal a deal.
Former Woolworths exec claims ‘boys club’ culture in Fair Work suit
Supermarket giant Woolworths has been hit with a lawsuit by a former senior executive who claims she was forced to work up to 90 hours per week and was subjected to a "boys club" culture.
Construction PRO
Lendlease, Charter Hall strike deal on Sydney CBD properties  
Charter Hall has signed a deal to take over a Sydney office precinct from Lendlease.
AUSTRAC has ‘serious concerns’ about Tabcorp’s compliance
AUSTRAC has opened an investigation into betting company Tabcorp’s compliance with anti-money laundering laws. 
Pharmacor can challenge patent term extension in AstraZeneca case
Pharmacor, which is facing infringement claims by AstraZeneca over its plans to launch a generic version of diabetes drug Forxiga, can tweak its cross-claim to challenge a patent term extension.